A Gene Therapy Company Leading Neural Regeneration and Repair
About Us
NeuExcell is an early stage gene therapy company focusing on neurodegenerative diseases. We have developed a disruptive neural repair technology that utilizes in vivo astrocyte-to-neuron conversion.
Our vision is to improve the quality of life of millions of patients worldwide who are suffering from neurodegenerative conditions by using the power of gene therapy to restore damaged neural tissue.
Highly Experienced Management Team

Ronald HW Lorijn, MD, PhD
Chief Executive Officer

Gong Chen, PhD
Founder,
Chief Scientific Officer

Xi Qin
Chief Financial Officer

Elizabeth White, PhD
Chief Business & Strategy Officer

Jie Xu
Co-Founder,
Head of Discovery

Peter Tombros
Board Chair